NCT06514976招募中不适用
Multi-center International Observational Study of Efficiency of the Drug Cytoflavin®, Solution for Infusions in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy.
POLYSAN Scientific & Technological Pharmaceutical Company17 个研究点 分布在 1 个国家目标入组 562 人开始时间: 2024年3月1日最近更新:
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 562
- 试验地点
- 17
- 主要终点
- Percentage of patients with favorable functional outcome (score 0-2) according to Modified Rankin Scale (mRS) on Day of Discharge (assessment at Visit 4 or Visit 5, on Day of Discharge) and on Day 90;
研究概览
简要总结
Stroke remains one of the main socially significant problems in the healthcare in the third millennium. The lethality in persons with history of stroke by the end of the 1st year of disease is high. A trend to increased frequency of stroke in the young age is observed during the last decade; third of patients is working-age individuals, out of whom only 15-20% returns to labor, and others remain disabled persons requiring constant medical and social support
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed informed consent form
- •Age from 18 years and older
- •Diagnosis: Acute cerebrovascular accident of ischemic type (ischemic stroke) developed within 36 hours before enrollment in the study
- •Motor neurologic deficit measurable using the NIHSS Scale (score for item 5 and/or 6 at the time of starting the therapy ≥ 1))
- •Conservative stroke treatment tactics (without reperfusion therapy thrombolysis/thrombus extraction)
- •According to the routine clinical practice, the patient is scheduled to receive the treatment as per one of the following regimens:
- •Cytoflavin® 20-40 ml/day as a course of not less than 10 days or
- •another neuroprotector - course of not less than 10 days (or without neuroprotector)
排除标准
- •NIHSS 1a (coma) score 3 at the time of enrollment
- •Initial severe disablement (corresponding to mRS > 2) requiring external assistance in everyday life before development of stroke
- •History of Parkinson's disease, dementia, multiple sclerosis, and other significant diseases accompanied by neurologic deficit
- •Severe comorbidity with expected lifespan of not more than 6 months
- •Pregnancy and breastfeeding
- •Any other concomitant medical or serious psychic conditions, which make the patient ineligible for participation in the study, restrict lawfulness of obtaining the informed consent, or can influence the patient's ability to participate in the study
研究组 & 干预措施
The test group
Basic therapy + Cytoflavin
干预措施: Cytoflavin (Drug)
结局指标
主要结局
Percentage of patients with favorable functional outcome (score 0-2) according to Modified Rankin Scale (mRS) on Day of Discharge (assessment at Visit 4 or Visit 5, on Day of Discharge) and on Day 90;
时间窗: Base, day 14, day 21, day 90
Modified Rankin Scale (mRS)
次要结局
- Total score according to Modified Rankin Scale (mRS) on Day of Discharge and Day 90 in the test and control group;(Day 14, day 21, day 90)
- Total score according to Rivermead Scale on Day 7, Day 14, Day 21, and Day 90 in the test and control group(Day 7, day 14, day 21, day 90)
- Change of the total score according to Stroke-Specific Quality of Life Scale (SS-QOL) on Day 90 as compared to Day of Discharge;(Day 14, day 21, day 90)
- Change of the total score according to National Institute of Health Stroke Scale (NIHSS) on Day 3, Day 7, Day 14, and Day 21 as compared to the baseline level (Day 1);(Day 7, day 14, day 21, day 90)
- Percentage of patients with repeated ACVA or TIA during the study;(Day 90)
- Percentage of patients with lethal outcome in the period of hospitalization and follow-up(Day 90)
研究者
研究点 (17)
Loading locations...
相似试验
招募中
不适用
Multidimensional Evaluation of Patients With Acute Ischemic Stroke Undergoing Pharmacological and Endovascular Revascularization Procedures for the Identification of Positive Prognostic FactorsEndovascular ThrombectomyIschemic StrokeStrokeNCT05708079Fondazione Policlinico Universitario Agostino Gemelli IRCCS600
Unknown
不适用
Incidence and Risk Factors of Peri-operative Stroke in Non-cardiac,Non-neurosurgical SurgeriesPeri-operative StrokePerioperative Adverse EventsNon-cardiac SurgeryNon-neurosurgical SurgeryNCT01758952Chinese Medical Association10,000
已完成
不适用
Robot-Assisted Rehabilitation in Individuals With StrokeStrokeNCT05550311Biruni University34
Unknown
不适用
A Trial of Intravascular Hypothermia Therapy in Acute Ischemic Stroke PatientsReperfusion InjuryIschemic StrokeThrombectomyHypothermiaNCT04695236jiaoliqun80
Unknown
不适用
A Multi-center Clinical Study on the Status of Trauma Evaluating Ability in Patients With Multiple TraumaMultiple Trauma/InjuriesNCT03791333Peking University People's Hospital3,600